Pete's Money Makers

Collapse
This topic is closed.
X
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Peter Hansen
    Banned
    • Jul 2005
    • 3968

    Ski

    Ski between the dope and the hot Viet girls .......no wonder we lost the war LOL!

    Comment

    • skiracer
      Senior Member
      • Dec 2004
      • 6314

      Originally posted by Peter Hansen View Post
      Ski between the dope and the hot Viet girls .......no wonder we lost the war LOL!
      it was the only time and place that i have experienced where you could get high on almost anything that you desired, then they gave you a weapon and ammo, and turned you loose in the jungle where you could take any vietnamese woman you wanted if that was your thing, ravage a village without any ramifications, and kill knowing that no one is going to bother you about it. or be killed all while stoned on great weed. it was as close to the old west as you could get. especially if you were part of a special group and not part of the general army population. but none of that was the reason we supposedly "lost the war".
      THE SKIRACER'S EDGE: MAKE THE EDGE IN YOUR FAVOR

      Comment

      • Websman
        Senior Member
        • Apr 2004
        • 5545

        Originally posted by skiracer View Post
        it was the only time and place that i have experienced where you could get high on almost anything that you desired, then they gave you a weapon and ammo, and turned you loose in the jungle where you could take any vietnamese woman you wanted if that was your thing, ravage a village without any ramifications, and kill knowing that no one is going to bother you about it. or be killed all while stoned on great weed. it was as close to the old west as you could get. especially if you were part of a special group and not part of the general army population. but none of that was the reason we supposedly "lost the war".
        Too bad somebody didn't take Hanoi Jane out....

        Comment

        • billyjoe
          Senior Member
          • Nov 2003
          • 9014

          Webs,
          Were you old enough to take her out in her prime? http://www.cinemaretro.com/uploads/jane_fonda.jpg
          Maybe now that she's more mature
          404 - Page not found - Contactmusic.com is the premier destination for official music videos, music reviews | Contactmusic.com



          --------------billy

          Comment

          • Peter Hansen
            Banned
            • Jul 2005
            • 3968

            Ski

            Originally posted by skiracer View Post
            it was the only time and place that i have experienced where you could get high on almost anything that you desired, then they gave you a weapon and ammo, and turned you loose in the jungle where you could take any vietnamese woman you wanted if that was your thing, ravage a village without any ramifications, and kill knowing that no one is going to bother you about it. or be killed all while stoned on great weed. it was as close to the old west as you could get. especially if you were part of a special group and not part of the general army population. but none of that was the reason we supposedly "lost the war".
            Ski God bless ya ...I guess one's primary job in Vietnam was .."Trying To Stay Alive" My hat is off to anyone who went there! Thanx for the honest evaluation of the war .......one which was never carried on the TV news .

            Comment

            • Peter Hansen
              Banned
              • Jul 2005
              • 3968

              10 For 4/29/10

              Today we have a mixed bag of 10 stocks with some nice charts.

              1. AEHR LONG Testing systems for memory devices
              2. ALXA LONG Super Sweet Biopharma with a "STEADY" rising chart. 5 Drugs in late stage development!
              3. DCTH LONG Phenominal rising chart , BUT overextended ....caution is advised! Manufactures devices for Chemotherapy Drug treatment
              4. DDD LONG A bio company that manufacturers prescription, over the counter , and nutritional products. This $1.19 stock is ready to pop!
              5. GDX LONG Gold Miner Index .."SAFER" Gold play
              6. LPHI LONG An UNDERVALUED. Current price is $23.91 , but should be $46.23, Pays annual $1.25 Dividend or 5.2%. Finaancial services for insurance products.
              7. LBY LONG Glass company with sweet chart.
              8. IEZ LONG An Oil Equipment Services ETF
              9. O LONG Realty Services. One to buy and tuck away in a ROTH IRA ! Can you imagine that O was founded in 1969 and has paid over 463 monthly dividends , and raised its dividend each quarter . Currently pays $1.72 annual Dividend per share or 5.2%. O only buys convenience stores. gas stations, chain restuarants, daycare centers and then leases back the propeties with long term leases and bump up rental agreements . Slick because they never invest in pet monkey stores or car dealers ...those busineses that you see with CLOSED signs in the windows!
              10 TGB LONG Small Gold miner

              Good Luck, God Bless, and enjoy the beautiful day!

              Comment

              • riverbabe
                Senior Member
                • May 2005
                • 3373

                Dndn -- yes!!!

                Dendreon's Provenge approved by FDA a few minutes ago! Stock halted. But showing up almost 16% in a matter of minutes! In at 39.33, showing 45.50.
                Last edited by riverbabe; 04-29-2010, 01:15 PM.

                Comment

                • riverbabe
                  Senior Member
                  • May 2005
                  • 3373

                  DNdn FDA news release - for you guys



                  FDA Approves a Cellular Immunotherapy for Men with Advanced Prostate Cancer

                  The U.S. Food and Drug Administration today approved Provenge (sipuleucel-T), a new therapy for certain men with advanced prostate cancer that uses their own immune system to fight the disease.

                  Provenge is indicated for the treatment of asymptomatic or minimally symptomatic prostate cancer that has spread to other parts of the body and is resistant to standard hormone treatment.

                  Prostate cancer is the second most common type of cancer among men in the United States, behind skin cancer, and usually occurs in older men. In 2009, an estimated 192,000 new cases of prostate cancer were diagnosed and about 27,000 men died from the disease, according to the National Cancer Institute.

                  “The availability of Provenge provides a new treatment option for men with advanced prostate cancer, who currently have limited effective therapies available,” said Karen Midthun, M.D., acting director of the FDA’s Center for Biologics Evaluation and Research.

                  Provenge is an autologous cellular immunotherapy, designed to stimulate a patient’s own immune system to respond against the cancer. Each dose of Provenge is manufactured by obtaining a patient’s immune cells from the blood, using a machine in a process known as leukapheresis. To enhance their response against the cancer, the immune cells are then exposed to a protein that is found in most prostate cancers, linked to an immune stimulating substance. After this process, the patient’s own cells are returned to the patient to treat the prostate cancer. Provenge is administered intravenously in a three-dose schedule given at about two-week intervals.

                  The effectiveness of Provenge was studied in 512 patients with metastatic hormone treatment refractory prostate cancer in a randomized, double-blind, placebo-controlled, multicenter trial, which showed an increase in overall survival of 4.1 months. The median survival for patients receiving Provenge treatments was 25.8 months, as compared to 21.7 months for those who did not receive the treatment.

                  Almost all of the patients who received Provenge had some type of adverse reaction. Common adverse reactions reported included chills, fatigue, fever, back pain, nausea, joint ache and headache. The majority of adverse reactions were mild or moderate in severity. Serious adverse reactions, reported in approximately one quarter of the patients receiving Provenge, included some acute infusion reactions and stroke. Cerebrovascular events, including hemorrhagic and ischemic strokes, were observed in 3.5 percent of patients in the Provenge group compared with 2.6 percent of patients in the control group.

                  Provenge is manufactured by Seattle-based Dendreon Corp.
                  Last edited by riverbabe; 04-29-2010, 01:44 PM. Reason: add link

                  Comment

                  • riverbabe
                    Senior Member
                    • May 2005
                    • 3373

                    Dndn

                    This is huge folks! Listen to Conference Call at 2:30 PM today.

                    Comment

                    • Peter Hansen
                      Banned
                      • Jul 2005
                      • 3968

                      River Thanx For the DNDN Info

                      River DNDN seems super ......but I beleive those who are not already in DNDN have missed the boat?

                      Comment

                      • riverbabe
                        Senior Member
                        • May 2005
                        • 3373

                        Originally posted by Peter Hansen View Post
                        River DNDN seems super ......but I beleive those who are not already in DNDN have missed the boat?
                        Pete, IMHO only for the short term maybe late to get in. But longer term looks like a very promising investment. They are 25% geared up in their NJ facility and plan to treat first patient next week.

                        It's more a lesson I'm trying to bring to the table. When it comes to short term investing in biotech, aim for companies that are showing successful Phase III clinical trials and submitting their results to the FDA for approval. A year ago, Dendreon did this but the FDA asked for more info. Now finally gets approval. All of these are long haul situations. Stretching patience for the short term/swing trader like me. I only got into DNDN (for the second time in 2 years) three weeks ago (late but still a gamble) when I realized the FDA decision was close and the data was fabulous.

                        A lot of people on the Zoo board have been in for years, since it was a 2-4 dollar stock. Check out the monthly chart to see the patience required and all the going thru the wringer. That's why I think it's only a certain type of investor or trader that has the chutzpah to grit their teeth for the long haul. Which is what it takes to invest in biotech. And an awful lot of the biotech stocks you list are definitely not for the short term trader or the faint of heart. And there are probably a lot of winners buried there. I'm just gonna wait till they get further along.

                        Stock just trading again at around 51 and humongous volume. Still holding.

                        Riverbabe
                        Last edited by riverbabe; 04-29-2010, 04:15 PM. Reason: monthly chart, not yearly

                        Comment

                        • riverbabe
                          Senior Member
                          • May 2005
                          • 3373

                          Hot Tip

                          Rumor has it that DNDN winners are going to switch to DCTH. Only rumor.

                          DCTH is another company with a fabulous product waiting for FDA approval and positive Phase III results. Disclosure: I'm in this one too. Dredre was the person who brought it to the board, and I thank him. Worth a look because it just might be on it's way up again, overextended or not. JMHO.
                          Last edited by riverbabe; 04-29-2010, 04:13 PM.

                          Comment

                          • Peter Hansen
                            Banned
                            • Jul 2005
                            • 3968

                            11 For Friday 3/30/10

                            Wow hard to beleive another month has passed ..where has all the time gone?
                            Mixed bag today .....stock futures appear to be higher as I write so here we go , and hopefully this "GOLDEN ELEVEN " will provide us with some great profits!

                            1. ALXA Super Biopharma that is a steady climber with 5 druga in late satge development!
                            2. AGM LONG Federal Agricultural Mortgage stock that keeps on climbing
                            3. BXG LONG Vacation clubs and real estate ...never believed in this high pressure sales BS .....but apparently the suckers are piling in and the chart looks SUPER!
                            4. DCTH Bio PHarma Exteed and may take a breather here ...but should still continue higher!
                            5. DNDN LONG Shot up 25% yesterday .......BioPharma maybe buy after pullback?
                            6. JBFCF.PK LONG Yes a PINK SHEET HIGH RISK STOCK currently at $1.30 BUY if it hits $1.34 and then place mental stop at $!.24 According to Stock Gumshoe this JBFCF.PK is a SCREAMING BUY and could be the Next McDonalds . Read all about it here http://www.stockgumshoe.com/2010/04/...-investor.html
                            7. LION LONG Financial
                            8. SBSA LONG Spainish Broadcasting Breaking out again!
                            9. SMTX Advanced electronics manufacturing
                            10. SIGM LONG manufacturers digutal media processors
                            11. SGMO LONG Another BioPharama which appeas to be slowly rising

                            Good Luck God Bless ......and have a beautiful weekend!

                            Comment

                            • edward
                              Senior Member
                              • Jun 2009
                              • 124

                              LION-I bought in a couple of weeks ago and have seen nice steady increases to a 36% gain. I believe that this one has a long way to go yet. $18-$20 not out of the possibilities here and the company is a good takeover target as well.

                              Comment


                              • Hey Pete, thanks for the heads up on APKT back in early December. I did my homework on it and got in at $11.40.
                                Now I need to figure out when to sell?
                                Thanks again!

                                -Bill

                                Comment

                                Working...
                                X